This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
home:mp:break [05.10.2014] – [To resume the MP] joyful | home:mp:break [09.14.2022] (current) – external edit 127.0.0.1 | ||
---|---|---|---|
Line 5: | Line 5: | ||
- | The Marshall Protocol (MP) is a curative medical treatment, which allows patients to make progress by activating the innate immune response. In the process, this generates immunopathology. | + | The Marshall Protocol (MP) is a curative medical treatment, which allows patients to make progress by activating the innate immune response |
- | The length of time it takes for antibiotics to no longer have an effect is variable. Determining factors include how long the antibiotics stay in one's system (often a month or more) as well as how self-sufficient the immune system is. Patients in later stages of treatment may find their immune response is relatively self-sustaining, | + | For those who have added antibiotics, |
Patients are advised not to discontinue olmesartan (Benicar), as the drug is palliative and protects organs. | Patients are advised not to discontinue olmesartan (Benicar), as the drug is palliative and protects organs. | ||
Line 39: | Line 39: | ||
So, again, thank you, and do let us know how things are going from time to time. | So, again, thank you, and do let us know how things are going from time to time. | ||
- | p.s., our new MP knowledge base provides links to recent papers, publications, | + | p.s., our new MP knowledge base provides links to recent papers, publications, |
// | // | ||
Line 58: | Line 58: | ||
For patients who take a break over more than a month, it may be best to start over with minocycline alone and only add a second antibiotic once the immunopathology indicates they are ready for additional immune stimulation. | For patients who take a break over more than a month, it may be best to start over with minocycline alone and only add a second antibiotic once the immunopathology indicates they are ready for additional immune stimulation. | ||
+ | |||
+ | |||
==== Stopping olmesartan (Benicar) not recommended ==== | ==== Stopping olmesartan (Benicar) not recommended ==== | ||
+ | {{section>: | ||
- | {{section>: | ||
==== Using valsartan for organ protection during weaning olmesartan ==== | ==== Using valsartan for organ protection during weaning olmesartan ==== | ||
{{section>: | {{section>: | ||
- | |||
- | |||
- | |||
Line 81: | Line 80: | ||
==== Vitamin D consumption ==== | ==== Vitamin D consumption ==== | ||
- | MP patients taking a break from treatment should continue to avoid all forms of ingested vitamin D during the break. | + | MP patients taking a break from treatment should continue to avoid all forms of ingested vitamin D during the break as symptom instability often results. |
+ | |||
===== If immunopathology continues unabated ===== | ===== If immunopathology continues unabated ===== | ||
Line 98: | Line 99: | ||
- | ===== Does disease become worse if on Benicar | + | ===== Does disease become worse on olmesartan |
- | + | ||
- | Latent bacterial forms, except maybe the kind one sees in the rapidly degenerative disease ALS, are very slow-growing. Patients taking Benicar alone (olmesartan without antibiotics) are continuing to experience some level of the symptoms of immunopathology, | + | |
+ | Latent bacterial forms, except maybe the kind one sees in the rapidly degenerative disease ALS, are very slow-growing. Patients taking Benicar alone (olmesartan without antibiotics), | ||
Line 108: | Line 107: | ||
===== Resuming olmesartan after a break ===== | ===== Resuming olmesartan after a break ===== | ||
- | MP patients who have discontinued olmesartan (Benicar) during a break from the MP will want to take olmesartan | + | MP patients who have discontinued olmesartan (Benicar) during a break from the MP will want to restart regular dose olmesartan without additional antibiotics. Once symptoms have stabilized on olmesartan along, it will be easier to determine how strong their own immune response |
Line 116: | Line 115: | ||
===== Patients experiences ===== | ===== Patients experiences ===== | ||
- | < | + | < |
//**John McDonald**, MarshallProtocol.com// | //**John McDonald**, MarshallProtocol.com// | ||
+ | |||
+ | {{tag> | ||
+ | < | ||
===== Notes and comments ===== | ===== Notes and comments ===== | ||
Line 128: | Line 130: | ||
* Legacy content | * Legacy content | ||
- | * http:// | + | * https:// |
- | * http:// | + | * https:// |
- | * http:// | + | * https:// |
+ | </ | ||